A citation-based method for searching scientific literature

Yan Zheng, Sylvia H Ley, Frank B Hu. Nat Rev Endocrinol 2018
Times Cited: 1084







List of co-cited articles
201 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Type 2 diabetes mellitus.
Ralph A DeFronzo, Ele Ferrannini, Leif Groop, Robert R Henry, William H Herman, Jens Juul Holst, Frank B Hu, C Ronald Kahn, Itamar Raz, Gerald I Shulman,[...]. Nat Rev Dis Primers 2015
462
7

Mechanisms linking obesity to insulin resistance and type 2 diabetes.
Steven E Kahn, Rebecca L Hull, Kristina M Utzschneider. Nature 2006
6

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
6

Type 2 diabetes.
Sudesna Chatterjee, Kamlesh Khunti, Melanie J Davies. Lancet 2017
632
5

Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends.
Moien Abdul Basith Khan, Muhammad Jawad Hashim, Jeffrey Kwan King, Romona Devi Govender, Halla Mustafa, Juma Al Kaabi. J Epidemiol Glob Health 2020
111
5

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Francesco Cosentino, Peter J Grant, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen,[...]. Eur Heart J 2020
921
5

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
5

A metagenome-wide association study of gut microbiota in type 2 diabetes.
Junjie Qin, Yingrui Li, Zhiming Cai, Shenghui Li, Jianfeng Zhu, Fan Zhang, Suisha Liang, Wenwei Zhang, Yuanlin Guan, Dongqian Shen,[...]. Nature 2012
5

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
5

The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
Christian Bommer, Esther Heesemann, Vera Sagalova, Jennifer Manne-Goehler, Rifat Atun, Till Bärnighausen, Sebastian Vollmer. Lancet Diabetes Endocrinol 2017
241
4

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
4

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
4

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
4

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
N Sarwar, P Gao, S R Kondapally Seshasai, R Gobin, S Kaptoge, E Di Angelantonio, E Ingelsson, D A Lawlor, E Selvin, M Stampfer,[...]. Lancet 2010
4

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
4


Standards of medical care for type 2 diabetes in China 2019.
Weiping Jia, Jianping Weng, Dalong Zhu, Linong Ji, Juming Lu, Zhiguang Zhou, Dajin Zou, Lixin Guo, Qiuhe Ji, Li Chen,[...]. Diabetes Metab Res Rev 2019
116
3

Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies.
Manuela Neuenschwander, Aurélie Ballon, Katharina S Weber, Teresa Norat, Dagfinn Aune, Lukas Schwingshackl, Sabrina Schlesinger. BMJ 2019
89
3


Richness of human gut microbiome correlates with metabolic markers.
Emmanuelle Le Chatelier, Trine Nielsen, Junjie Qin, Edi Prifti, Falk Hildebrand, Gwen Falony, Mathieu Almeida, Manimozhiyan Arumugam, Jean-Michel Batto, Sean Kennedy,[...]. Nature 2013
3

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
D R Matthews, J P Hosker, A S Rudenski, B A Naylor, D F Treacher, R C Turner. Diabetologia 1985
3

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.
Merlin C Thomas, Mark E Cooper, Paul Zimmet. Nat Rev Nephrol 2016
217
3

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
Eri T Kato, Michael G Silverman, Ofri Mosenzon, Thomas A Zelniker, Avivit Cahn, Remo H M Furtado, Julia Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter,[...]. Circulation 2019
217
3

Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program.
Brendon L Neuen, Toshiaki Ohkuma, Bruce Neal, David R Matthews, Dick de Zeeuw, Kenneth W Mahaffey, Greg Fulcher, Qiang Li, Meg Jardine, Richard Oh,[...]. J Am Soc Nephrol 2019
44
6

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Mikhail Kosiborod, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jørgensen, Marcus Thuresson,[...]. Circulation 2017
450
3

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
3

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program.
Karin Rådholm, Gemma Figtree, Vlado Perkovic, Scott D Solomon, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Terrance D Barrett, Wayne Shaw, Mehul Desai,[...]. Circulation 2018
219
3

Gut microbial metabolites in obesity, NAFLD and T2DM.
Emanuel E Canfora, Ruth C R Meex, Koen Venema, Ellen E Blaak. Nat Rev Endocrinol 2019
283
3

Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes.
Liping Zhao, Feng Zhang, Xiaoying Ding, Guojun Wu, Yan Y Lam, Xuejiao Wang, Huaqing Fu, Xinhe Xue, Chunhua Lu, Jilin Ma,[...]. Science 2018
620
3

Type 2 diabetes as an inflammatory disease.
Marc Y Donath, Steven E Shoelson. Nat Rev Immunol 2011
3

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites.
Ara Koh, Filipe De Vadder, Petia Kovatcheva-Datchary, Fredrik Bäckhed. Cell 2016
3



Role of self-care in management of diabetes mellitus.
Saurabh Rambiharilal Shrivastava, Prateek Saurabh Shrivastava, Jegadeesh Ramasamy. J Diabetes Metab Disord 2013
285
3

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.
Michael Ej Lean, Wilma S Leslie, Alison C Barnes, Naomi Brosnahan, George Thom, Louise McCombie, Carl Peters, Sviatlana Zhyzhneuskaya, Ahmad Al-Mrabeh, Kieren G Hollingsworth,[...]. Lancet 2018
515
3

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
3

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
3

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
3

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
3

Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis.
Marijana Vujkovic, Jacob M Keaton, Julie A Lynch, Donald R Miller, Jin Zhou, Catherine Tcheandjieu, Jennifer E Huffman, Themistocles L Assimes, Kimberly Lorenz, Xiang Zhu,[...]. Nat Genet 2020
68
4

The integrative biology of type 2 diabetes.
Michael Roden, Gerald I Shulman. Nature 2019
168
3

Diabetes mellitus and the β cell: the last ten years.
Frances M Ashcroft, Patrik Rorsman. Cell 2012
532
3


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
2

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
2

Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.
Darryl P Leong, Koon K Teo, Sumathy Rangarajan, Patricio Lopez-Jaramillo, Alvaro Avezum, Andres Orlandini, Pamela Seron, Suad H Ahmed, Annika Rosengren, Roya Kelishadi,[...]. Lancet 2015
702
2

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
2

Postprandial Saturated Fatty Acids Increase the Risk of Type 2 Diabetes: A Cohort Study in a Chinese Population.
Yanjiao Wang, Xing Meng, Xinrui Deng, Akinkunmi Paul Okekunle, Peng Wang, Qiao Zhang, Lingyu Ding, Xinxin Guo, Mengfan Lv, Changhao Sun,[...]. J Clin Endocrinol Metab 2018
5
40

Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.
Nita G Forouhi, Albert Koulman, Stephen J Sharp, Fumiaki Imamura, Janine Kröger, Matthias B Schulze, Francesca L Crowe, José María Huerta, Marcela Guevara, Joline W J Beulens,[...]. Lancet Diabetes Endocrinol 2014
279
2

Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies.
Vibha Rani, Gagan Deep, Rakesh K Singh, Komaraiah Palle, Umesh C S Yadav. Life Sci 2016
382
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.